Leonore Tiefer

Leonore Tiefer
none · none

PhD

About

163
Publications
20,481
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
3,503
Citations
Citations since 2017
37 Research Items
759 Citations
2017201820192020202120222023050100150
2017201820192020202120222023050100150
2017201820192020202120222023050100150
2017201820192020202120222023050100150
Introduction

Publications

Publications (163)
Article
Full-text available
The US Food and Drug Administration (FDA) has approved two drugs for 'hypoactive sexual desire disorder' in women, flibanserin (Addyi) in 2015 and bremelanotide (Vyleesi) in 2019. In this paper we examine the outcome measures and clinical trial data upon which regulatory approval was based. In clinical trials, flibanserin led to an average of only...
Chapter
Female Genital Cosmetic Surgery - edited by Sarah M. Creighton February 2019
Article
Full-text available
An analysis of the cultural and economic drivers of the growing phenomenon of FGCS, written by cross-disciplinary experts, this book challenges the concept of individual consumer choice in FGCS: A decision that is rarely exercised in a socio-cultural vacuum. Four distinct aspects of FGCS are covered: Variations in female genital anatomy; surgical t...
Book
Revisits and updates the centrality of the social construction of sexuality, especially in the age of Viagra, FSD (female sexual dysfunction) and the media saturation of sex. Leonore Tiefer is one of the foremost sexologists working in the United States today; she is a well-known and respected scholar who writes engagingly and humorously about a wi...
Article
Full-text available
Criticisms and controversies about scientific method are rarely just about science. As or more often, they are sociological exercises in boundary patrol, helping determine which work is in and which is out. The recent back-and-forth on the question of whether psychological treatments for sexual desire complaints are sufficiently “rigorous” is part...
Article
Full-text available
There were numerous missed opportunities at the October 2014 U.S. Food and Drug Administration (FDA) meeting on female sexual dysfunction (FSD). They included opportunities to hear from a diverse range of patients and to engage in evidence-based discussions of unmet medical needs, diagnostic instruments, trial end points, and inclusion criteria for...
Article
Physicians are not well prepared to address patients' concerns about their sexual behavior or to diagnose sexual dysfunction, owing to their limited personal and clinical experience and education on the topic.
Article
Full-text available
A narrative of my first months as a breast cancer patient offers insight into how a feminist meets a biomedical crisis. Instead of consulting other women and feminist texts, I initially immersed myself in scientific information-gathering, only realizing later that decision-making is best done with feminist resources as well as medical experts. The...
Article
in this chapter I will present some key elements in the social constructionist approach and indicate how and why current psychological writing and research about human sexuality is dominated by a limiting, medicalized perspective / I hope to show how a transformed perspective offers social and personality psychologists exciting opportunities for sc...
Article
This special issue grows out of the need to bring into focus the historical and sociocultural contextualization of sex to the sexological community. The specific focus is on analyzing how medicalization is affecting many areas of sexual life and discourse, but the larger goal is to help situate sexuality studies in its broadest perspective. Article...
Article
Full-text available
This article complicates recent discussions about the expanding zones and influences of medicalization and biomedicalization on sexuality and sex therapy by contextualizing them with competing nonmedicalizing trends. These latter developments include an escalating nonexpert commercial sexuality sector on the Internet, as well as a long history of a...
Article
Full-text available
The New View Campaign is a grassroots initiative begun in 1999 to challenge the over-medicalization of sex in the wake of publicity following the release of Viagra. This paper describes the history of the campaign and its activities, which started with analysing the construction of female sexual dysfunction, and moved on to develop a critical under...
Chapter
Expectations and standards for women’s sexual lives are a matter of wide cultural variation and continual historical change (1–3). At the beginning of the 21st century, cultural and social shifts that affect women’s sexuality are being brought about by globalization, women’s liberation, commercialization, medicalization, and new media technologies....
Article
Full-text available
This special issue of Feminism & Psychology presents a sampling of the type of work stimulated by The New View Campaign against the medicalization of sex, c. 2008. In this introduction, I offer a brief history of the New View Campaign (1999—2008) and show how the articles in this special issue illustrate many of its major themes. In closing, I sugg...
Article
Full-text available
Female genital cosmetic surgery (FGCS) refers to new treatment/enhancement technologies that have engendered much controversy. Examining FGCS through the lenses of bioethics, feminist theory and medical marketing situates it within makeover culture and deregulatory politics, and links it to feminist debates about making choices within constrained c...
Article
Full-text available
Contemporary sexology is fragmented, with the new sexuality studies almost completely split off from the new sexual therapies. Clinical sexology research and practice are in danger of being captured by commercial interests, chiefly the global pharmaceutical industry. One solution to both of these intellectual problems comes from an examination of t...
Article
Subversive Dialogues: Theory in Feminist Therapy, Laura S. Brown. New York: Basic Books, 1994. 258 pp., $33.00 (cloth), ISBN: 0-465-08322–6.
Article
Full-text available
The Association for Women in Psychology (AWP) was founded in 1969 by American Psychological Association (APA) members who were frustrated with sexism in psychology, in the APA, and at the 1969 APA convention itself. The activism of the 1960s, together with the new women's liberation movement, gave the founders tools and justification for a new orga...
Article
Full-text available
Contemporary constructions of sexuality can change direction faster than a competitive ballroom dancer and it can be hard to keep track of all the new developments. Regulatory regimes abound and even proliferate yet mass media proclaim the end of the double standard and the advent of sexual emancipation. In 1998, in yet another major twist, a new s...
Article
Disease-mongering in the case of sexual problems has some special elements. These include that discussions of sex provoke embarrassment and reveal a lack of knowledge on the part of both clinician and patient, the aggressiveness of Big Pharma in the face of the huge profitability of sexual products; and the socially constructed nature of sexual sat...
Article
Full-text available
Tiefer highlights key steps in the "creation" of a new diagnosis, female sexual dysfunction, and of the campaign to challenge its reductionist approach to women's sexual problems.
Article
Medicalization is a key process of social change and social influence. It occurs not merely because of scientific developments, but because biomedical claims are actively promoted by those with professional and economic interests in expanding medical domains. This article examines how women’s sexual health is being medicalized by the pharmaceutical...
Article
Medicalization of female sexual problems is a social process with intellectual as well as practical implications. It is promoted actively by the pharmaceutical industry and the lobby of urologists which before had been involved in the development of Sildenafil in order to set up a new market for pharmaceutic products and medical services. Unexpexte...
Article
Full-text available
Since 1945, United Nations (UN) conferences and documents have promoted human rights as essential to individual liberty and international peace. It took until 1994, however, for the term "sexual rights" to first appear in a UN document. Recently, other groups have also been promoting the idea of sexual rights. The professional and scientific World...
Article
Editor—The subject of the medicalisation of sexual behaviour requires an even larger perspective than that offered by Hart and Wellings,1 one specifically identifying socioeconomic trends and agents. For example, the addition of sexual dysfunctions to the American psychiatric nomenclature in 1980 came at a time when psychiatry needed to become more...
Article
Women's sexual lives have changed dramatically in the past four decades. The liberalization of women's sexuality has fostered new professional and academic interest in women's sexual lives, and escalating numbers of conferences, books, research projects and internet websites now address girls' and women's sexualities from several points of view. Al...
Article
A new theoretical framework and classification system for women's sexual problems, written by feminist clinicians and social scientists, was released in October 2000. Part one critiques the current American Psychiatric Association nomenclature for women's sexual programs. Part two highlights international sexual rights documents. Part three begins...
Article
This first conference on female sexual dysfunction (FSD) offers researchers and clinicians an important opportunity to add to the already sizeable literature on contemporary women's sexual problems. However, this opportunity is threatened by commercial domination and an excessively narrow biomedical focus which neglects the research and theory grow...
Article
Full-text available
This document was written by a group of 12 clinicians and social scientists and released at a press conference on October 25, 2000. The 1st part criticizes current American Psychiatric Association nomenclature for women's sexual problems because of false equivalency between men and women, erasing the relational contact of sexuality, and ignoring di...
Article
Full-text available
This essay offers an all-embracing narrative of the “new view” project to explain how and why a feminist critique of current sex problem nomenclature, an alternative vision, and an activist campaign have emerged since 1999. The story begins with 15 years of urology-promoted medicalization of men's sexuality and the building of a female market near...
Article
Full-text available
This essay offers an all-embracing narrative of the "new view" project to explain how and why a feminist critique of current sex problem nomenclature, an alternative vision, and an activist campaign have emerged since 1999. The story begins with 15 years of urology-promoted medicalization of men's sexuality and the building of a female market near...
Article
Full-text available
In recent years, the pharmaceutical industry has become very interested in sex as a focus for drug development and marketing. Many sexologists have embraced this new trend, particularly because of greatly welcomed research funding and increased professional opportunities. However, this new relationship may be a Faustian bargain, and certainly raise...

Network

Cited By

Projects

Project (1)